IBM Watson collaborates with Broad Institute to explore genomics data
Category: #health  By Paroma Bhattacharya  Date: 2019-02-15
  • share
  • Twitter
  • Facebook
  • LinkedIn

IBM Watson collaborates with Broad Institute to explore genomics data

The initiative is expected enhance understanding of intrinsic possibility that individuals have for any specific disease.

IBM Watson Health, a cognitive healthcare solution company recently announced multiple new partnership deals. One of them is a collaborative deal with the Broad Institute of MIT and Harvard.

The IBM division that is based in Cambridge, Massachusetts, has been reported to say that the extended collaboration with Broad Institute is aimed at exploring and analyzing genomics data for the enhanced understanding of intrinsic possibility that individuals have for any specific disease.

IBM Watson has been reported to say that through the newly formed initiative, the company will be working to incorporate hospital and population-based biobank data, electronic health records and genomic information to improve genetic risk scoring. The project also aims at making its tools and insights available to the research community. Such tools include means for genome variants-based calculation of an individual’s risk of developing common diseases.

Sekar Kathiresan, Director, Broad Institute cardiovascular disease initiative has been reported to say that the institute is looking forward to developing upon the advances it has made in the field of polygenic risk scoring with the vast amount of genomic data. He added that the addition of clinical data with genomic data creates an excellent opportunity to enhance polygenic risk scoring and makes it more robust and powerful, transforming patient care.

According to sources, the recent deal is an expansion on a five-year deal previously signed by the groups in 2016. The initial phase of the new project will be undertaken for three years.

John Kelly, Senior Vice President, IBM Watson Health, has been reported to say in an official press release that the company is working directly with physician-scientists of Broad Institute to enhance AI to help it unlock undiscovered clues in the human health. He said that IBM Watson Health has built a deep expertise in the application of AI for understanding the complexities and meaning of massive amounts of genomics and health records data. He added that the latest collaboration is expected to combine such capabilities with clinical insights and improve technology’s chances of providing explicable insights to clinicians in the study and treatment of serious health conditions.



About Author

Paroma Bhattacharya

Email: [email protected]   

Paroma Bhattacharya

Paroma currently works as a content developer for Algosonline, MSF and a series of alike platforms. Fortified with a post-graduation degree in Journalism and Mass Communication, she delved head long into a writing career, creating resourceful and information enriched ...

Read More

More News By Paroma Bhattacharya

MacroGenics, I-Mab team up to develop & market enoblituzumab in China
MacroGenics, I-Mab team up to develop & market enoblituzumab in China
By Paroma Bhattacharya

MacroGenics, Inc. and I-Mab Biopharma, a U.S. and China based clinical-stage biopharmaceutical company that is committed to discover and develop biologics in autoimmune and immune-oncology diseases, have recently announc...

ViiV Healthcare announces positive result in TANGO Phase 3 study
ViiV Healthcare announces positive result in TANGO Phase 3 study
By Paroma Bhattacharya

ViiV Healthcare Limited, a pharmaceutical company specializing in HIV treatment, recently announced positive results from Phase 3 TANGO study.

The study was conducted to assess vira...

Skyhawk Therapeutics expands licensing partnership with Biogen
Skyhawk Therapeutics expands licensing partnership with Biogen
By Paroma Bhattacharya

Skyhawk Therapeutics, Inc. has recently announced the expansion of its partnership with Biogen, which was initially announced on January 4, 2019.

The expansion, which leverages on the breadth of SkySTAR™ technology platform from Skyh...